David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$345M |
| 2 |
Biogen
BIIB
|
+$281M |
| 3 |
Bausch Health
BHC
|
+$244M |
| 4 |
SPDR Gold Trust
GLD
|
+$238M |
| 5 |
Coca-Cola
KO
|
+$206M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$397M |
| 2 |
AGN
Allergan Inc
AGN
|
+$374M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$347M |
| 4 |
Microsoft
MSFT
|
+$265M |
| 5 |
IBM
IBM
|
+$251M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 10.34% |
| 2 | Technology | 9.79% |
| 3 | Consumer Discretionary | 9.73% |
| 4 | Healthcare | 8.68% |
| 5 | Financials | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VRTV
1051
DELISTED
VERITIV CORPORATION
VRTV
| $8.45M | 0.01% |
191,528
-18,489
| -9% | -$923K |
|
|
DNB
1052
DELISTED
Dun & Bradstreet
DNB
| $8.45M | 0.01% |
65,827
-12,365
| -16% | -$1.55M |
|
|
GMCR
1053
PUT
DELISTED
KEURIG GREEN MTN INC
GMCR
| $8.45M | 0.01% |
75,600
-106,800
| -59% | -$13.4M |
|
1054
Greif
GEF
$4.85B
| $8.42M | 0.01% |
214,452
+166,564
| +348% | +$6.81M |
|
1055
CALL
Lowe's Companies
LOW
$121B
| $8.42M | 0.01% |
113,200
+12,500
| +12% | +$896K |
|
|
CYBX
1056
DELISTED
CYBERONICS INC
CYBX
| $8.34M | 0.01% |
+128,436
| New | +$7.82M |
|
|
BRLI
1057
DELISTED
BIO-REFERENCE LABS INC-NEW-
BRLI
| $8.32M | 0.01% |
236,040
-27,927
| -11% | -$945K |
|
1058
PUT
Petrobras
PBR
$115B
| $8.31M | 0.01% |
1,382,900
-1,617,800
| -54% | -$10.3M |
|
1059
CALL
Salesforce
CRM
$168B
| $8.29M | 0.01% |
124,000
-388,100
| -76% | -$24.1M |
|
|
MSCC
1060
DELISTED
Microsemi Corp
MSCC
| $8.27M | 0.01% |
233,609
+196,598
| +531% | +$6.08M |
|
1061
Nektar Therapeutics
NKTR
$2.55B
| $8.24M | 0.01% |
49,912
+23,350
| +88% | +$4.8M |
|
|
CLR
1062
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $8.21M | 0.01% |
187,936
-34,677
| -16% | -$1.47M |
|
|
QIHU
1063
PUT
DELISTED
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
| $8.19M | 0.01% |
160,000
-231,000
| -59% | -$12.5M |
|
1064
PUT
Boston Beer
SAM
$1.94B
| $8.18M | 0.01% |
30,600
+20,300
| +197% | +$5.88M |
|
1065
CALL
Avis
CAR
$5.15B
| $8.18M | 0.01% |
138,600
-29,800
| -18% | -$1.82M |
|
1066
PUT
Elevance Health
ELV
$86.7B
| $8.15M | 0.01% |
52,800
-50,000
| -49% | -$7.12M |
|
1067
Martin Marietta Materials
MLM
$37.9B
| $8.14M | 0.01% |
+58,247
| New | +$7.48M |
|
|
COWN
1068
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $8.14M | 0.01% |
391,401
+102,363
| +35% | +$1.99M |
|
1069
Comscore
SCOR
$76.1M
| $8.13M | 0.01% |
7,938
+4,838
| +156% | +$4.56M |
|
1070
Ziff Davis
ZD
$1.89B
| $8.12M | 0.01% |
+142,215
| New | +$7.92M |
|
|
HPTX
1071
DELISTED
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
| $8.12M | 0.01% |
176,831
+6,104
| +4% | +$183K |
|
|
1072
CALL
Coca-Cola
KO
$395B
| $8.11M | 0.01% |
200,000
-400,000
| -67% | -$16.7M |
|
1073
CALL
Kroger
KR
$35.7B
| $8.1M | 0.01% |
211,400
-108,400
| -34% | -$3.87M |
|
1074
PUT
Teva Pharmaceuticals
TEVA
$44B
| $8.1M | 0.01% |
130,000
-775,800
| -86% | -$45.1M |
|
1075
Sasol
SSL
$7.34B
| $8.1M | 0.01% |
+237,804
| New | +$8.55M |
|
Similar funds
David Shaw's Q1 2015 Portfolio in Review
As of Q1 2015, David Shaw held 4,408 positions worth $65.3B, down 16% from $77.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $15B in Q1 2015, closing 828 positions and reducing 1,784 holdings. Its most notable exit was Allergan Inc, an estimated $374M position sold in full.
By sector, the portfolio is most concentrated in Energy at 10% of assets, up from 8.6% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, David Shaw opened a new position in SPDR Gold Trust worth $231M.
- David Shaw's largest Q1 2015 buy was SPDR Gold Trust: 2,033,000 shares worth $231M.
- David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q1 2015, an estimated $345M increase.
- David Shaw's biggest Q1 2015 reduction was LyondellBasell Industries, cutting an estimated $397M.
- David Shaw fully exited Allergan Inc in Q1 2015, selling an estimated $374M.
- David Shaw's ten largest holdings make up 11% of its $65.3B portfolio in Q1 2015.
- David Shaw opened 448 new positions and closed 828 in Q1 2015.
- David Shaw's portfolio value fell 16% quarter-over-quarter to $65.3B.
Based on D.E. Shaw & Co's 13F filing for Q1 2015, filed 15 May 2015.